News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biologics, Inc. (NC) Selected By Ariad Pharmaceuticals, Inc. (ARIA) To Be The Exclusive Specialty Pharmacy Provider For Iclusig (Ponatinib)


1/13/2014 10:51:43 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CARY, N.C.--(BUSINESS WIRE)--Biologics, Inc., an integrated oncology services company, is pleased to announce that it has been selected by ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) to be the sole specialty pharmacy provider of Iclusig® (ponatinib) and manager of its Patient Access and Support Services (ARIAD PASSTM) program. Iclusig is a treatment for adult patients with refractory chronic myeloid leukemia or Philadelphia-chromosome positive (Ph+) acute lymphoblastic leukemia.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES